InvestorsHub Logo
Followers 32
Posts 746
Boards Moderated 0
Alias Born 03/13/2018

Re: None

Thursday, 09/06/2018 4:38:02 PM

Thursday, September 06, 2018 4:38:02 PM

Post# of 111073
My expectation is that more than one ticker is eagerly awaiting the peer reviewed results from our good ol' CELZ clinical study because that along with patient testimonials can unlock FDA approvals for others.

This is why I think the company is doing this completely by the numbers and playing it all very close to the chest. When they have confidence their conclusions will survive scrutiny, it'll be 'katie bar the door' in this stem cell space and our CELZ holds a patent that will need to be enforced.

Too exciting!

-Go CELZ$$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News